Clicks GroupJSE:CLS -2.49%85 ROE % is 47.26% as of Feb. 2026, which is 7% above its 10-year median of 43.98. GuruFocus rates JSE:CLS with a GF Score™ of 85/100 and a GF Value™ of R384.72 (Significantly Undervalued). Among 625 Healthcare Providers & Services companies, Clicks Group ranks better than 95.2% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Clicks Group's annualized net income for the quarter that ended in Feb. 2026 was R3,060 Mil. Clicks Group's average Total Stockholders Equity over the quarter that ended in Feb. 2026 was R6,474 Mil. Therefore, Clicks Group's annualized ROE % for the quarter that ended in Feb. 2026 was 47.26%.
The historical rank and industry rank for Clicks Group's ROE % or its related term are showing as below:
JSE:CLS'
s ROE % Range Over the Past 10 Years
Min: 36.76 Med: 43.98 Max: 51.67
Current: 51.67
During the past 13 years, Clicks Group's highest ROE % was 51.67%. The lowest was 36.76%. And the median was 43.98%.
JSE:CLS's ROE % is ranked better than 95.2% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs JSE:CLS: 51.67
Clicks Group (JSE:CLS) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Feb. 2026) net income data. The Revenue data used here is two times the semi-annual (Feb. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Clicks Group ROE % Related Terms
Clicks Group ROE % Historical Data
* Premium members only.
The historical data trend for Clicks Group's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Clicks Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's ROE % distribution charts can be found below:
* The bar in red indicates where Clicks Group's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Feb. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Clicks Group (JSE:CLS) has a ROE % of 47.26% as of Feb. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Clicks Group and its competitors. This is near median its historical median of 43.98. Over the past decade, Clicks Group's ROE % has ranged from 36.76 to 51.67. According to the industry distribution chart, Clicks Group ranks #30 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 4.8%.
Is Clicks Group's ROE % too high?
Clicks Group's current ROE % of 47.26% is near median its 10-year median of 43.98. Over the past 10 years, this metric has ranged from a low of 36.76 to a high of 51.67. The Healthcare Providers & Services industry median ROE % is 5.84. Clicks Group's value of 47.26% is 709.2% above this industry median. Based on the distribution chart, Clicks Group ranks #30 out of 625 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clicks Group has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #30 out of 625 companies for ROE %. This places Clicks Group in the top 5% of its industry — outperforming the majority of peers. The industry median ROE % is 5.84. Clicks Group's value of 47.26% is 709.2% above this benchmark. Historically, Clicks Group's own ROE % has ranged from 36.76 to 51.67 over the past decade. While the company's 10-year median is 43.98 vs. the industry median of 5.84, Clicks Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current ROE % of 47.26% is 709.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Clicks Group and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current ROE % is 47.26%, which is near median its own 10-year median of 43.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (JSE:CLS) is currently considered Significantly Undervalued. The stock's GF Value™ is R384.72, compared to a current price of R221.00 — trading 42.6% below its estimated fair value. The current ROE % is 47.26%, which is near median its 10-year median of 43.98 and 709.2% above the Healthcare Providers & Services industry median of 5.84. Clicks Group's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Clicks Group (JSE:CLS), the current ROE % is 47.26% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (JSE:CLS) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of R221.00 is trading 42.6% below its estimated GF Value™ of R384.72.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for JSE:CLS:
ROE %: 47.26% (near median its 10-year median of 43.98)
GF Value™: R384.72 vs. price of R221.00 (42.6% below fair value)
Industry Position: 709.2% above the Healthcare Providers & Services median (#30 of 625)
No single metric tells the full story. See the JSE:CLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
85GF Score
Get the complete analysis for JSE:CLS
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CLS has been successfully added to your 
